In addition, inhibiting Src or JNK diminished the APC-mediated cell proliferation, suggesting that targeted inhibition of these signaling pathways downstream FAK appears as a promising strategy in APC-mutated breast cancers. This evidence concerns the gene SRC and breast cancer.